Viridian Therapeutics Inc (VRDN) support and resistance · rev $425.0K
Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
This page maps Viridian Therapeutics Inc (VRDN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VRDN revenue for 2026-06-30 was $425.0K. Net income was -$232.0M. VRDN currently screens at market cap $1.39B.
VRDN currently screens at market cap $1.39B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VRDN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VRDN quote page for the session range and the stock page for the full model.
Not investment advice.